PMID- 22658696 OWN - NLM STAT- MEDLINE DCOM- 20130418 LR - 20151119 IS - 1876-4738 (Electronic) IS - 0914-5087 (Linking) VI - 60 IP - 3 DP - 2012 Sep TI - Comparison of inflammatory markers between diabetic and nondiabetic ST segment elevation myocardial infarction. PG - 204-9 LID - S0914-5087(12)00088-3 [pii] LID - 10.1016/j.jjcc.2012.03.006 [doi] AB - BACKGROUND: Inflammation plays a significant role in acute coronary syndrome (ACS) and type 2 diabetes mellitus (DM). There may be similar inflammatory changes in non-DM patients with ST elevation myocardial infarction (STEMI) and DM patients with stable angina (SA), and DM patients with STEMI may have more severe changes than the former two groups. The objectives of this study were to investigate whether the level of inflammation was similar in patients with non-DM STEMI and DM SA, and to evaluate whether the changes in the level of inflammation were more severe in patients with DM STEMI compared to the other two groups. METHODS AND RESULTS: A variety of inflammatory markers including: highly sensitive C-reactive protein (hsCRP), erythrocyte sedimentation rate (ESR), interleukin-6 (IL-6), IL-18, vascular cell adhesion molecule-1 (VCAM-1), and matrix metallopeptidase-9 (MMP-9) as well as insulin resistance were compared among the three groups: DM STEMI (90 patients), DM SA (91 patients), and non-DM STEMI (76 patients). Inflammatory marker levels were not significantly different between the DM SA and non-DM STEMI groups. However, hsCRP and IL-6 were increased in the DM STEMI compared to the DM SA patients (p=0.005 and p=0.004, respectively). In addition, hsCRP, ESR, and IL-18 were increased in the DM STEMI compared to the non-DM STEMI patients (p=0.017, p=0.020, and p=0.033, respectively). Furthermore, the fasting insulin and the homeostasis model assessment were significantly increased in the DM STEMI compared to the DM SA patients (p=0.04 and p=0.004, respectively). CONCLUSIONS: DM SA and non-DM STEMI may have similar inflammatory changes. DM STEMI may be a more severe inflammatory condition compared to patients with DM SA or non-DM STEMI. CI - Copyright (c) 2012 Japanese College of Cardiology. Published by Elsevier Ltd. All rights reserved. FAU - Heo, Ji Man AU - Heo JM AD - Department of Cardiology, Cardiovascular Center, Korea University Anam Hospital, Seoul, Republic of Korea. FAU - Park, Jae Hyoung AU - Park JH FAU - Kim, Ju Hyeon AU - Kim JH FAU - You, Sung Hae AU - You SH FAU - Kim, Je Sang AU - Kim JS FAU - Ahn, Chul-Min AU - Ahn CM FAU - Hong, Soon Jun AU - Hong SJ FAU - Shin, Kyung-Ho AU - Shin KH FAU - Lim, Do-Sun AU - Lim DS LA - eng PT - Comparative Study PT - Journal Article PT - Research Support, Non-U.S. Gov't DEP - 20120531 PL - Netherlands TA - J Cardiol JT - Journal of cardiology JID - 8804703 RN - 0 (Biomarkers) RN - 0 (Interleukin-18) RN - 0 (Interleukin-6) RN - 0 (Vascular Cell Adhesion Molecule-1) RN - 9007-41-4 (C-Reactive Protein) RN - EC 3.4.24.35 (Matrix Metalloproteinase 9) SB - IM MH - Angina, Stable/complications MH - Biomarkers/blood MH - Blood Sedimentation MH - C-Reactive Protein/analysis MH - Diabetes Mellitus, Type 2/*complications MH - Electrocardiography MH - Female MH - Humans MH - Inflammation/*blood MH - Insulin Resistance MH - Interleukin-18/blood MH - Interleukin-6/blood MH - Male MH - Matrix Metalloproteinase 9/blood MH - Middle Aged MH - Myocardial Infarction/*blood/complications/*physiopathology MH - Vascular Cell Adhesion Molecule-1/blood EDAT- 2012/06/05 06:00 MHDA- 2013/04/20 06:00 CRDT- 2012/06/05 06:00 PHST- 2011/12/22 00:00 [received] PHST- 2012/03/10 00:00 [revised] PHST- 2012/03/13 00:00 [accepted] PHST- 2012/06/05 06:00 [entrez] PHST- 2012/06/05 06:00 [pubmed] PHST- 2013/04/20 06:00 [medline] AID - S0914-5087(12)00088-3 [pii] AID - 10.1016/j.jjcc.2012.03.006 [doi] PST - ppublish SO - J Cardiol. 2012 Sep;60(3):204-9. doi: 10.1016/j.jjcc.2012.03.006. Epub 2012 May 31.